Cargando…

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Antiviral drug development for coronavirus disease 2019 (COVID-19) is occurring at an unprecedented pace, yet there are still limited therapeutic options for treating this disease. We hypothesized that combining drugs with independent mechanisms of action could result in synergy against SARS-CoV-2,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobrowski, Tesia, Chen, Lu, Eastman, Richard T., Itkin, Zina, Shinn, Paul, Chen, Catherine Z., Guo, Hui, Zheng, Wei, Michael, Sam, Simeonov, Anton, Hall, Matthew D., Zakharov, Alexey V., Muratov, Eugene N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834738/ https://www.ncbi.nlm.nih.gov/pubmed/33333292 http://dx.doi.org/10.1016/j.ymthe.2020.12.016

Ejemplares similares

Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Allosteric binders of ACE2 are promising anti-SARS-CoV-2 agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents
por: Hochuli, Joshua E., et al.
Publicado: (2022)

Deep learning identifies synergistic drug combinations for treating COVID-19
por: Jin, Wengong, et al.
Publicado: (2021)

Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021)

The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators
por: Gorshkov, Kirill, et al.
Publicado: (2020)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

Application of temperature-responsive HIS-tag fluorophores to differential scanning fluorimetry screening of small molecule libraries
por: Ronzetti, Michael H., et al.
Publicado: (2022)

Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infection
por: Shamim, Khalida, et al.
Publicado: (2021)

Discovery of Small Molecule Entry Inhibitors Targeting the Fusion Peptide of SARS-CoV-2 Spike Protein
por: Hu, Xin, et al.
Publicado: (2021)

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay
por: Hanson, Quinlin M., et al.
Publicado: (2020)

The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
por: Gorshkov, Kirill, et al.
Publicado: (2020)

COVID-KOP: Integrating Emerging COVID-19 Data with the ROBOKOP Database
por: Korn, Daniel, et al.
Publicado: (2020)

COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database
por: Korn, Daniel, et al.
Publicado: (2020)

Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants
por: Jain, Sankalp, et al.
Publicado: (2021)

COVID-19 Knowledge Extractor (COKE): a tool and a web portal to extract drug - target protein associations from the CORD-19 corpus of scientific publications on COVID-19
por: Korn, Daniel, et al.
Publicado: (2020)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2021)

A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry
por: Xu, Miao, et al.
Publicado: (2022)

Discovery of TMPRSS2 inhibitors from virtual screening
por: Hu, Xin, et al.
Publicado: (2021)

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19
por: Hu, Xin, et al.
Publicado: (2021)

Learning from history: do not flatten the curve of antiviral research!
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Identifying Small Molecule Compounds that Have Synergistic Effects With Cisplatin and Other Platinum Drugs Using High Throughput Matrix Screening
por: Al-Zubi, Layla, et al.
Publicado: (2022)

A Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
por: Shrimp, Jonathan H., et al.
Publicado: (2022)

A humanized nanobody phage display library yields potent binders of SARS CoV-2 spike
por: Fu, Ying, et al.
Publicado: (2022)

High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations
por: Mott, Bryan T., et al.
Publicado: (2015)

Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing
por: Cohen, Phillip, et al.
Publicado: (2023)

Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing
por: Cohen, Phillip, et al.
Publicado: (2023)

Parallels in the pathogenesis of SARS-CoV-2 and M. tuberculosis: a synergistic or antagonistic alliance?
por: Tapela, Kesego, et al.
Publicado: (2021)

A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model
por: Dorjsuren, Dorjbal, et al.
Publicado: (2022)

Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2
por: Renn, Alex, et al.
Publicado: (2020)

An OpenData portal to share COVID-19 drug repurposing data in real time
por: Brimacombe, Kyle R., et al.
Publicado: (2020)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Identification of SARS-CoV-2 viral entry inhibitors using machine learning and cell-based pseudotyped particle assay
por: Sun, Hongmao, et al.
Publicado: (2021)

Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19
por: Eastman, Richard T., et al.
Publicado: (2020)

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
por: Eastman, Richard T., et al.
Publicado: (2020)

Synergistic and Antagonistic Drug Combinations Depend on Network Topology
por: Yin, Ning, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kt8ujbimgd9fmjsojg5g676s5j